Clinical Trial Update: Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating cetuximab, oxaliplatin, fluorouracil, and radiation therapy for stage II or stage III esophageal cancer; the status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FLUOROURACIL (Fluorouracil)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Technical University of Munich | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: UNKNOWN